These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12543685)
21. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase. Tahar R; Basco LK Am J Trop Med Hyg; 2007 Aug; 77(2):214-20. PubMed ID: 17690389 [TBL] [Abstract][Full Text] [Related]
22. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand. Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545 [TBL] [Abstract][Full Text] [Related]
23. Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria. Lanaspa M; Moraleda C; Machevo S; González R; Serrano B; Macete E; Cisteró P; Mayor A; Hutchinson D; Kremsner PG; Alonso P; Menéndez C; Bassat Q Antimicrob Agents Chemother; 2012 Jun; 56(6):2923-8. PubMed ID: 22430959 [TBL] [Abstract][Full Text] [Related]
24. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Phyo AP; Jittamala P; Nosten FH; Pukrittayakamee S; Imwong M; White NJ; Duparc S; Macintyre F; Baker M; Möhrle JJ Lancet Infect Dis; 2016 Jan; 16(1):61-69. PubMed ID: 26448141 [TBL] [Abstract][Full Text] [Related]
25. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Karbwang J; Bangchang KN; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T Lancet; 1992 Nov; 340(8830):1245-8. PubMed ID: 1359318 [TBL] [Abstract][Full Text] [Related]
26. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643 [TBL] [Abstract][Full Text] [Related]
27. Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria. Oyakhirome S; Issifou S; Pongratz P; Barondi F; Ramharter M; Kun JF; Missinou MA; Lell B; Kremsner PG Antimicrob Agents Chemother; 2007 May; 51(5):1869-71. PubMed ID: 17325227 [TBL] [Abstract][Full Text] [Related]
28. Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC. Konzuch S; Umeda T; Held J; Hähn S; Brücher K; Lienau C; Behrendt CT; Gräwert T; Bacher A; Illarionov B; Fischer M; Mordmüller B; Tanaka N; Kurz T J Med Chem; 2014 Nov; 57(21):8827-38. PubMed ID: 25254502 [TBL] [Abstract][Full Text] [Related]
29. The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum. Dumont L; Richardson MB; van der Peet P; Marapana DS; Triglia T; Dixon MWA; Cowman AF; Williams SJ; Tilley L; McConville MJ; Cobbold SA mBio; 2019 Dec; 10(6):. PubMed ID: 31822583 [TBL] [Abstract][Full Text] [Related]
30. Metabolic Survival Adaptations of Plasmodium falciparum Exposed to Sublethal Doses of Fosmidomycin. Tewari SG; Rajaram K; Swift RP; Reifman J; Prigge ST; Wallqvist A Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495219 [TBL] [Abstract][Full Text] [Related]
31. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria. Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666 [TBL] [Abstract][Full Text] [Related]
32. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653 [TBL] [Abstract][Full Text] [Related]
33. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents. Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024 [TBL] [Abstract][Full Text] [Related]
34. Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. Laochan N; Zaloumis SG; Imwong M; Lek-Uthai U; Brockman A; Sriprawat K; Wiladphaingern J; White NJ; Nosten F; McGready R Malar J; 2015 May; 14():221. PubMed ID: 26017553 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors. Haemers T; Wiesner J; Van Poecke S; Goeman J; Henschker D; Beck E; Jomaa H; Van Calenbergh S Bioorg Med Chem Lett; 2006 Apr; 16(7):1888-91. PubMed ID: 16439126 [TBL] [Abstract][Full Text] [Related]
36. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Adjuik M; Agnamey P; Babiker A; Borrmann S; Brasseur P; Cisse M; Cobelens F; Diallo S; Faucher JF; Garner P; Gikunda S; Kremsner PG; Krishna S; Lell B; Loolpapit M; Matsiegui PB; Missinou MA; Mwanza J; Ntoumi F; Olliaro P; Osimbo P; Rezbach P; Some E; Taylor WR Lancet; 2002 Apr; 359(9315):1365-72. PubMed ID: 11978332 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224 [TBL] [Abstract][Full Text] [Related]
38. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004 [TBL] [Abstract][Full Text] [Related]
39. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. Looareesuwan S; Wilairatana P; Viravan C; Vanijanonta S; Pitisuttithum P; Kyle DE Am J Trop Med Hyg; 1997 Jun; 56(6):613-7. PubMed ID: 9230790 [TBL] [Abstract][Full Text] [Related]
40. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]